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EH16Abstract—The acoustic properties of two clinical (Definity, LantheusMedical Imaging, North Billerica,MA, USA;
SonoVue, Bracco S.P.A., Milan, Italy) and one pre-clinical (MicroMarker, untargeted, Bracco, Geneva,
Switzerland; VisualSonics, Toronto, ON, Canada) ultrasound contrast agent were characterized using a broad-
band substitution technique over the ultrasound frequency range 12–43 MHz at 20 ± 1C. At the same number
concentration, the acoustic attenuation and contrast-to-tissue ratio of the three native ultrasound contrast agents
are comparable at frequencies below 30 MHz, though their size distributions and encapsulated gases and shells
differ. At frequencies above 30MHz, native MicroMarker has higher attenuation values and contrast-to-tissue ra-
tios than native Definity and SonoVue. Decantation was found to be an effectivemethod to alter the size distribution
and concentration of native clinical microbubble populations, enabling further contrast enhancement for specific
pre-clinical applications. (E-mail: carmel.moran@ed.ac.uk)  2014 World Federation for Ultrasound in Med-
icine & Biology.
Key Words: High-frequency ultrasound, Microbubble, Attenuation, Contrast-to-tissue ratio, Pre-clinical,
Decantation.INTRODUCTION
High-frequency ultrasound (.20 MHz) is used to obtain
high-spatial-resolution images for the imaging of intra-
vascular structures (Rhee 2007), superficial tissues
(Vogt et al. 2007) and pre-clinical animal models
(Foster et al. 2011; Goertz et al. 2005; Sun et al. 2008)
and in ophthalmology (Silverman et al. 2008).
Ultrasound contrast agents (UCAs) are gas-filled
microbubbles (MBs) and are used clinically as blood
pool tracers to significantly enhance the acoustic back-
scatter from blood. Definity (Lantheus Medical Imaging,
North Billerica, MA, USA) and SonoVue (Bracco S.P.A.,
Milan, Italy) are two clinically licensed UCAs. Micro-
Marker (targeted and untargeted) (Bracco, Geneva,
Switzerland; VisualSonics, Toronto, ON, Canada) is mar-
keted as a pre-clinical UCA for contrast enhancement and
molecular imaging in small animals. The fundamental
backscatter response and duration of enhancement of
Definity have been characterized in mice at 40 MHz atddress correspondence to: Carmel M. Moran, Room E3.06,
for Cardiovascular Science, Queen’s Medical Research Institute,
sity of Edinburgh, 47 Little France Crescent, Edinburgh, UK
4TJ. E-mail: carmel.moran@ed.ac.uk
541a peak negative pressure of 3.5 MPa (Sirsi et al. 2010);
large Definity MBs (4–5 and 6–8 mm in diameter) were
found to have longer persistence and stronger contrast
enhancement than small MBs (1–2 mm in diameter).
This study also concluded that dissolution of the gas
core was the dominant mechanism of contrast decay
and was larger than filtration and removal of UCAs by
macrophages in the lung, liver and spleen. In another
study, the concentration-dependent attenuation and back-
scatter properties of Definity at 30 MHz were also inves-
tigated, both in vivo and in vitro; the results suggested that
doses between 10 and 60 mL kg21 produce a linear in-
crease in peak enhancement, and these doses were recom-
mended for quantitative contrast flow studies in mice
(Stapleton et al. 2009).
Attenuation of UCAs has previously been deter-
mined for in vitro experiments studying the fundamental
acoustic response of UCAs: Definity over 12–29 MHz
(Goertz et al. 2007) and over 5–15 MHz (Faez et al.
2011); SonoVue over 0.8–10 MHz (Gorce et al. 2000);
untargeted MicroMarker over 18–25 MHz (Huo et al.
2010); and targeted MicroMarker over 4–13.5 MHz
(Helfield and Goertz 2013). Data based on these results
can be used to calculate the shell properties used in simu-
lation studies of MB dynamics (Hoff 1996). Mean
542 Ultrasound in Medicine and Biology Volume 40, Number 3, 2014backscatter power and attenuation of lipid-encapsulated
Sonazoid (Nycomed, Oslo, Norway), Definity and Sono-
Vue and albumin-shelled Optison (Mallinckrodt, Hennef,
Germany) were measured at 30MHz as a function of con-
centration and time using an intravascular ultrasound
transducer (Moran et al. 2002, 2005). The concentration
range of 104 to 106 MBs mL21 was found to present a
linear relationship with mean backscatter power;
however, these measurements were not corrected for
attenuation caused by contrast in the intervening path.
According to the literature, alteration of the size dis-
tribution of MBs effectively changes the fundamental
(Sirsi et al. 2010) and harmonic (Cheung et al. 2008;
Goertz et al. 2003) responses when the MBs are
insonated with high-frequency ultrasound. However,
UCAs measured by various experimental setups give
varying results for shell, gas and size distribution of
MBs, and the differences in experimental methods cannot
be excluded as having an effect on the measured acoustic
response. Additionally, little work to date has discussed
the acoustic response of sub-populations in which the
boundary of the size distribution is determined based on
consideration of the simulated resonant MB diameter at
a specific applied frequency. Consequently, for pre-
clinical applications at high frequencies, it would be of
interest to compare the acoustics of three commercial
UCAs using one experimental setup and determine how
a specific size distribution influences the acoustic perfor-
mance of MBs.
The aim of the work described here was to study the
acoustic response at fundamental frequencies of three
commercially available ultrasonic contrast agents—Def-
inity, SonoVue and MicroMarker—as a function of size,
using a pre-clinical ultrasound scanner over the frequency
range 12–43 MHz at 20 6 1C. Based on the simulated
resonant diameter, two sub-populations are formed by
changing the size distribution through decantation of
the original population of MBs. The analysis combining
the measured size distribution and acoustic response of
different populations addresses the question of whichTable 1. Parameters and dilutions of th
Definity*
Gas C3F8 SF6
Shell Phospholipid Pho
Mean diameter (mm)x 1.1–3.3 2–3
Maximum concentration after
reconstitution (microbubbles/mL)
1.2 3 1010 5 3
Dilution in this study 1:15,000 1:6
Manufacturer Lantheus Medical,
North Billerica, MA, USA
Bra
* Lantheus Medical Imaging literature (2011).
y Gorce et al. (2000), Schneider (1999).
z VisualSonics literature (2012).
x Manufacturer’s literature.sub-population and which UCAs are most suitable for
enhancing the fundamental response at ultrasound fre-
quencies used for pre-clinical imaging.METHODS
Preparation of ultrasound contrast agents
Ultrasound contrast agents were reconstituted ac-
cording to the manufacturer’s guidelines and formed the
‘‘native MB population.’’ As the pre-reconstitution tem-
perature of Definity influences acoustic properties
(Helfield et al. 2012b), after removal from the fridge, Def-
inity vials were left for 15 min to reach room temperature
before activation. Based on the maximum concentration
(Table 1) from the manufacturer’s published literature,
MB mixtures were diluted in air-saturated, distilled water
at room temperature to reach the same concentration of
0.8 3 106 MBs mL21 and stirred for 1 min at 430 rpm
before measurement. This concentration falls within the
concentration regime previously reported to vary linearly
at 30 MHz (Stapleton et al. 2009). The same dilution was
employed in each sub-population of each UCA; the
method used to obtain sub-populations is described
below.Alteration of the size distribution of microbubbles by
decantation
Microbubbles were divided into two sub-
populations, referred to as large MBs and small MBs.
This was achieved using the method of decantation,
which has been found to be a simple method for altering
the size distribution of MBs (Goertz et al. 2007; Gorce
et al. 2000). For the specific decantation procedure, two
parameters including MB size and decantation time
were determined by calculating the resonance
frequency and employing the Stokes equation.
The diameter used to separate the MBs into large
and small populations was derived from the diameter of
resonant MBs at 12 MHz, which is the lower limit of
the frequency bandwidth used in this study. Thee three ultrasound contrast agents
SonoVuey MicroMarkerz
C4F10/N2
spholipid Polyethylene glycol, Phospholipids and fatty acid
2.3–2.9
108 2 3 109
25 1:2500
cco, Milan, Italy Bracco, Geneva, Switzerland;
VisualSonics, Toronto, ON, Canada
In vitro acoustic characterization of phospholipid UCAs d C. SUN et al. 543simulated resonance frequencies of Definity, SonoVue
and MicroMarker as a function of MB diameter are
plotted in Figure 1 on the basis of results derived from
Goertz et al. (2007) using de Jong’s MB spherical oscil-
lationmodel (de Jong et al. 1992). Shell parameters of the
three UCAs used in the simulations are listed in Table 2.
From these simulations, the critical size, defined as the
size below which the encapsulated MBs would never
resonate (Khismatullin 2004), was found to be 0.5 mm
for Definity, 1.5 mm for SonoVue and 1 mm for Micro-
Marker when insonated at 12 MHz. Above the critical
size, MBs with diameters less than 1.7 mm (Definity)
and 3.1 mm (MicroMarker) resonate at frequencies
higher than 12 MHz; no SonoVue MBs were found to
resonate at frequencies higher than 12 MHz. To our
knowledge, these simulations have not been confirmed
by experimental observations. However, even if there is
a small error associated with them, it is reasonable to as-
sume the size of 2 mm to separate SonoVue and Definity
MBs into small and large populations. In this study Mi-
croMarker was not decanted.
The estimated decantation time for acquiring MBs
of a specific diameter is derived from the Stokes equa-
tion, the principle of which is based on the varying times
of different-sized MBs floating a certain distance (Goertz
et al. 2007, eqn 12). The distance is determined by the
required volume and the shape of the container used for
decantation. In this study, 0.5 mL of 1-h-decanted Defi-
nity and 2 mL of 2-h-decanted SonoVue MBs were
selected to ensure the same dilutions as their correspond-
ing native populations. Collection of the decanted vol-
ume of UCA allows separation of the MBs that are
,2 mm in diameter (‘‘small MBs’’); the remaining MBs
are referred to as ‘‘large MBs’’ and are essentially the
native solution after removal of small MBs. The details
on decantation are given in Goertz et al. (2007). For the
measurements described below, the same dilution was
employed in each sub-population for the acoustic
measurements.
Measurement of size distribution and concentration
The size distributions of Definity, SonoVue and
MicroMarker MBs were determined with a laser
diffraction particle analyzer (Mastersizer 2000 Hydro
MU, Malvern Instruments, Malvern, UK). The Master-
sizer outputs the measured volume-based size dis-
tribution, and assuming the MBs are spherical, the
concentration of MBs can be estimated. For measure-
ments, the small and large MB populations were taken
from the same vial. Native MBs were taken from a sepa-
rate vial but from the same contrast agent batch. Three
consecutive measurements were made for each contrast
agent sample (in each sub-population: native, small and
large).Experimental setup
Experiments were performed based on a broadband
substitution technique (AIUM 1995) using the radiofre-
quency (RF) data from a Vevo 770 pre-clinical ultrasound
scanner (VisualSonics). This technique is described in
more detail in Sun et al. (2012) and briefly summarized
here. A circular water tank (7 cm in diameter, 4 cm in
height) was placed on a mixing/magnetic stirrer (RCT
Basic, IKAWorks, Wilmington, NC, USA). A magnetic
bar (3-mm o.d., 1 cm long) was placed in the tank to
ensure a homogeneous MB suspension. A transducer
was placed perpendicular to a polymethylpentene (TPX)
reflector (Boedeker Plastics, Shiner, TX, USA). The focal
position and region of interest (ROI) for the contrast-
to-tissue ratio (CTR) measurement are illustrated in
Figure 2.
Parameters of the four transducers (710B, 707B, 704
and 711) are listed in Table 3. Pulse length varied between
0.04 and 0.05 ms. As outlined in Table 3, the measured
center frequency of the transducers was lower than that
quoted by the manufacturer. The acoustic pressure from
the four transducers was measured with a polyvinylidene
fluoride membrane hydrophone (Precision Acoustics,
Dorchester, UK) with a 0.2-mm-diameter active element.
The acoustic pressure was measured over the range of
output powers on the Vevo 770 scanner for each trans-
ducer. For the attenuation and CTR, the transmitting
peak negative pressure (PNP) was set at 0.56 MPa in
response to the minimal power level for transducers
710B and 707B. For transducers 704 and 711, the PNP
was set at 0.58 MPa to approximate a PNP output compa-
rable to that exhibited by transducers 710B and 707B.Attenuation measurement
The attenuation coefficient was calculated by sub-
traction of the frequency spectra of the RF signals from
the TPX reflector with the MB suspension from the fre-
quency spectra obtained with water in the tank
(Coussios et al. 2004). The attenuation of the contrast
agent suspensions was calculated over a reduced 3-dB
frequency bandwidth of the transducers with a 5-MHz
reduction at the lower frequency limit of each of the trans-
ducer bandwidths because of limited sensitivity. The
attenuation coefficient a, in decibels per centimeter,
was calculated using the equation
a52
10
2d
log10
Id
I0
 
(1)
where I0 is the magnitude of the spectrum of the signal
from the reflector with the water in the tank; Id is the
magnitude of the power spectrum of the signal from the
reflector with the MBs in the tank; and d is the distance
from the transducer to the upper surface of the TPX
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Fig. 1. Simulated resonance frequency as a function of diameter
for Definity, SonoVue and MicroMarker at 12-MHz driving fre-
quency (derived from Goertz et al. [2007, eqn 7] using de Jong’s
model). The shell parameters of the three ultrasound contrast
agents used in the simulation of resonance frequency are listed
in Table 2.
544 Ultrasound in Medicine and Biology Volume 40, Number 3, 2014reflector and is equal to the focal depth. D is the distance
taken from the RF data of the scanner assuming a speed
of sound of 1540 m s21. The speed of sound, Vwater,
is from the published data (Bilaniuk and Wong 1993)
at a specific temperature. The actual physical distance
d between transducer and reflector is calculated as
d 5 (D/1540) 3 Vwater.
Additionally, to determine whether the insonation
PNP alters the acoustic properties of MBs, attenuation
measurements using native Definity were repeated four
times with 5-min intervals between scans in the same
contrast sample using transducer 707B at the 3% power
setting (PNP 5 0.56 MPa).
For attenuation measurement, each transducer ac-
quired 2700 measurements (three independent tests and
900 measurements per test), and the standard deviation
was calculated from the mean results from the three inde-
pendent tests.
Calculation of contrast-to-tissue ratio
The CTR was calculated by normalizing the mean
squared acoustic power of the backscattered signal
from the MB suspension to the mean squared acoustic
power of the backscattered signal of a tissue-
mimicking material (Sun et al. 2012) placed at the focusTable 2. Shell stiffness, Sp, and friction, Sf, o
UCA Measurement frequency range (MHz) Sp
Definity 12–28 1.71
SonoVue 0.8–3
MicroMarker 18–25
UCA 5 ultrasound contrast agent.
* Shell elasticity c5 5.15 N m21 and shell viscosity ks5 33 10
29 kg s21 (
(Doinikov and Bouakaz 2011).of the transducer, as illustrated in Figure 2. The back-
scattered power was calculated from the power spectra
of the received signal in frequency domain and
integrated over the measured 3-dB bandwidth of
the transducer (Table 3). Because the backscattered
tissue-mimickingmaterial signal wasmeasured in water,
the backscatter of the MB suspension was compensated
by the attenuation of the ultrasound (a) through the
MB suspension between the transducer and the upper
surface of the ROI (dup).
CTR5 10 log10
power backscatteredbubble
power backscatteredTMM
 
1a$2dup
(2)
The RF data in the pre-selected ROI (1.05 3 1.6 mm)
were saved and output, and MATLAB 2009A software
(The MathWorks, Natick, MA, USA) was used for
computational analysis. Each experiment was repeated
three times and 900 independent samples (300 consecu-
tive frames on three lines) in the ROI were collected
per experiment. Between adjacent RF acquisition lines,
the angle was less than 0.3 so the lines were assumed
to be parallel. The RF data on the three lines were found
to be independent from the autocorrelation calculations
(data not included).
RESULTS
Size distribution and concentration of microbubbles
Figure 3 illustrates the volume-based size distribu-
tions of Definity, SonoVue and MicroMarker. The two
percentages in the legends for Definity and SonoVue
are the percentages of the native population that lie below
and above 2 mm (the boundary). It can be seen that the
small MBs are successfully removed via decantation to
form the small MB population; however, small MBs still
exist in the large MB population (volume percentage:
27.51% in Definity and 8.04% in SonoVue).
Table 4 outlines the variation in calculated concen-
trations of the two decanted subpopulations compared
with the native population. For both Definity and Sono-
Vue, the concentration of the small MB population was
found to decrease, and the concentration of the large
MB population was found to increase, after decantation.f the three UCAs used in the simulation
(N m-1) Sf (310
26 kg s21) Reference
6 0.24 0.015 6 0.015 Goertz et al. (2007)
1.1 0.27 Gorce et al. (2000)
10.3* 0.15* Helfield et al. (2012)
Helfield et al. 2012) referred from Huo et al. (2010), Sp5 2c, Sf5 16pks
Fig. 2. Experimental setup for calculation of contrast-to-tissue
ratio measurement. (a) Backscattered signal from microbubble
suspension. (b) Backscattered signal from tissue-mimicking
material. dup 5 distance between the transducer and the
upper surface of the region of interest (ROI).
TPX 5 polymethylpentene.
In vitro acoustic characterization of phospholipid UCAs d C. SUN et al. 545Frequency-dependent attenuation of UCA suspensions
Figure 4 illustrates attenuation (dB cm21) as a func-
tion of frequency for the three UCAs. From the data
collected in this study over the frequency range
17–43 MHz, attenuation decreases with increasing fre-
quency for native Definity (Fig. 4a), SonoVue (Fig. 4b)
and MicroMarker (Fig. 4c). The variation in attenuation
over the frequency range 17–43 MHz for MicroMarker
is the smallest and is less than 2 dB cm21 in amplitude.
The results are in good agreement with the published
data for Definity (Goertz et al. 2007) and SonoVue
(Gorce et al. 2000). Furthermore, the variation in the
attenuation of ultrasound through native Definity sus-
pension is found to be less than 0.5 dB cm21 over the
frequency range 17–31 MHz from the four intermittent
measurements taken every 5 min.
Contrast-to-tissue ratio
Figure 5 illustrates the CTRs of the three popula-
tions (small, native and large) of SonoVue and Definity
and of native MicroMarker measured by the four trans-
ducers. The CTR of each native UCA decreases moreTable 3. Characteristics of four high-frequency
transducers*
RMV transducer model
710B 707B 704 711
Central frequency (MHz) 25 30 40 55
Focal length (mm) 15 12.7 6 6
Measured 3-dB bandwidth (MHz) 12–25 17–31 18–32 24–43
Measured central frequency (MHz) 18.5 24 25 33.5
Power 3% 3% 13% 50%
Peak negative pressure (MPa) 0.56 0.56 0.58 0.58
* The central frequency and focal length measurements are defined
by the manufacturer’s literature. The peak negative pressure was
measured with a membrane hydrophone and the 3-dB bandwidth was
measured from the frequency spectrum in response to the specific output
power setting of each transducer.than 5 dB from transducer 710 B (12–25 MHz) to trans-
ducer 711 (24–43MHz). The CTRs of Definity and Sono-
Vue measured by transducers 707 B and 704 are
comparable because of their similar driving frequency
range. For each subpopulation of Definity and SonoVue,
the large MB population produces the highest CTR.
Despite the differences in compositions and size distribu-
tions, when the three native native UCAs are measured
using the same transducer, the magnitudes of their
CTRs are approximately the same.DISCUSSION
Influence of decantation
In this study, decantation was chosen to alter the size
distribution of MBs. Its advantages over other methods
such as filtration (Cheung et al. 2008; de Jong et al.
1992) and centrifugation (Feshitan et al. 2009; Choi
et al. 2010; Streeter et al. 2010) are the ease of use of
the technique, the lack of compression force applied
and the ability to be able to preferentially select a size
distribution of interest. Talu et al. (2008) and Barrack
and Stride (2009) have reported the destruction of MBs
using narrow-gauge needles (0.241 mm in diameter for
25-G, 0.159 mm in diameter for 30-G needle). MBs
that either have been passed through a filter of diameter
generally ranging between 1 and 10 mm or have experi-
enced centrifugal forces are likely to be destroyed.
Another drawback of using a filter is that the selection
of MB size is directly restricted by the filter pore size
from the manufacturer. Additionally, both filtration
and centrifugation require pre-dilution of the agent.
Specifically, MBs usually require high dilution
(.1:1000), to allow sufficient space to isolate MBs in
centrifugation and to avoid clogging in filtration pores.
However, in vivo applications, especially small animal
injections, typically require a limited injection volume
(100 mL for mice [Foster et al. 2011]) and higher concen-
tration (e.g., MicroMarker 1 3 107 MBs in 50 mL per
injection) than laboratory in vitro experiments (e.g.,
0.8 3 106 MBs/mL applied in this study). The only lim-
itation of decantation is the time required to separate
the different size distributions.Influence of pressure on attenuation measurement
Transmitting pressure for the acoustic measurement
was set at 0.56 MPa (mechanical index [MI] 5 0.16 at
12-MHz frequency) and 0.58 MPa (MI 5 0.09 at
43-MHz frequency). Previous authors have found that
small, individual Definity and MicroMarker MBs
(,2 mm) are disrupted at 25 MHz using acoustic PNPs
ranging from 0.2 to 1 MPa (Helfield et al. 2012a), that
is, PNPs lower than that used in this study. However,
from our experiments (data not included), we found that
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Fig. 3. Volume-based size distributions of three populations of (a) Definity and (b) SonoVue and the single population of
(c) MicroMarker. The two percentages in parentheses in (a) and (b) are the percentages below and above 2 mm. The
maximum standard deviation of volume percentage was found to be less than 0.63%.
Table 4. Variation in percentage of concentrations of
small and large microbubbles compared with the native
population*
546 Ultrasound in Medicine and Biology Volume 40, Number 3, 2014the attenuation of ultrasound through native Definity sus-
pension does not vary with time over a 15-min period. This
indicates that the applied PNP is non-destructive and does
not change the acoustic properties of the MB suspension
over the measurement period. Note that in published atten-
uation experiments, Goertz et al. (2007) used 25 kPa over
the frequency range 12–29 MHz (maximal MI 5 0.007)
and Gorce et al. (2000) used 10 kPa over the frequency
range 0.8–10 MHz (maximal MI 5 0.011) as a transmit-
ting pressure sufficient to produce a small oscillation of
MBs. The attenuation measured at higher PNPs in this
study is similar in magnitude to these published data.
This implies that the attenuation of Definity and SonoVue
displays a low sensitivity to pressure at these low non-
destructive pressures over the frequency range 12–
43 MHz. However, further investigations of pressure
dependence are required to prove this hypothesis.Small microbubbles (%) Large microbubbles (%)
Definity 25.92 6 0.74 8.12 6 12.72
SonoVue 223.05 6 10.62 72.09 6 11.74
* Negative and positive numbers indicate decreases and increases in
concentration, respectively.Limitation of resonance frequency simulation
The attenuation values of native Definity (Fig. 4a)
and SonoVue (Fig. 4b) measured over 17–43 MHz are
consistent with published results at similar dilution ratios.De Jong et al. (1992) and Goertz et al. (2007) used values
of the magnitude of attenuation to determine the shell
stiffness and friction of MBs. The good agreement of
the measured attenuation at high frequencies with the
published results indicates the shell properties in
Table 2 are appropriate for use in the simulations illus-
trated in Figure 1. However, the equations for the calcula-
tion of resonance frequency are derived from small-scale
linear oscillations of encapsulated MBs, and the shell pa-
rameters in Table 2 are derived at frequencies different
from the range of interest in this study; hence it is possible
that the values of shell parameters may not be accurate.
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Fig. 4. Frequency-dependent attenuation of native ultrasound
contrast agents—(a) Definity, (b) SonoVue, (c) Micro-
Marker—measured by four transducers over their 3-dB band-
widths (5-MHz removal from the lower frequency end). (a,
Inset) Attenuation of Definity is compared with the experi-
mental results of Goertz et al. (2007). (b, Inset) Attenuation
of SonoVue is compared with the results of Gorce et al.
(2000). The concentration in Gorce and colleagues’ study
was 1:2000; therefore, the attenuation is corrected by multi-
plying by 3.2, as we used a 1:625 dilution. (c, Inset) Micro-
Marker. No attenuation curve has previously been published
for MicroMarker. For the attenuation measurement, each
transducer acquired 2700 measurements (three independent
tests and 900 measurements per test), and the standard
deviation was calculated from the means from the three inde-
pendent tests.
In vitro acoustic characterization of phospholipid UCAs d C. SUN et al. 547For example, 1-mm SonoVue was found to resonate at
21 MHz (Bouakaz and de Jong 2007), whereas according
to Figure 1, 1-mm SonoVue was found to be below the
critical size. However, the accuracy of the calculation of
the resonant frequency is not an absolute requirement
for this work. An approximate figure for the sizes of reso-
nating and non-resonating MBs can be attained using the
existing theory, and as indicated by the results, we
consider that this is an acceptable means of guiding size
fractionation.Influence of scattering cross section on contrast-to-
tissue ratio
It was found from the simulated resonance fre-
quency studies in Figure 1 that no SonoVue MBsFig. 5. Contrast-to-tissue ratios of small, native and large pop-
ulations of Definity and SonoVue and native population of Mi-
croMarker measured by the four transducers over their 3-dB
bandwidths. Error bars were calculated from three independent
measurements.
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Fig. 6. Simulation of scattering cross sections, ssc, of (a) Defi-
nity, (b) SonoVue and (c) MicroMarker as a function of fre-
quency at different diameters.
548 Ultrasound in Medicine and Biology Volume 40, Number 3, 2014resonated above 12 MHz. However, as illustrated in
Figure 5, we found that the CTR of native SonoVue
was comparable to that of Definity and MicroMarkerover the high frequency range. A comparison of the scat-
tering cross sections of the three UCAs may be helpful to
consider. The simulations of scattering cross-section
ssc(r, f) in de Jong et al. (1992, eqn 1) are plotted in
Figure 6, which gives the scattering cross sections of
the three UCAs for different sizes in the vicinity of the
estimated resonance diameters. It can be seen that over
the frequency range 10–45 MHz, the scattering cross sec-
tion of SonoVue microbubbles with diameter.2 mm is in
the same range (10–103 mm2) as Definity microbubbles of
diameter .0.7 mm and MicroMarker microbubbles of
diameter .0.7 mm. From Figure 3b, it is evident that
the volume percentage of native SonoVue microbubbles
is significantly greater than 2 mm, and hence the resultant
scattering cross sections of the SonoVue native popula-
tion may be comparable to those of Definity and
MicroMarker.
Impact of decantation on contrast-to-tissue ratio
For each UCA, the CTR of the native population
lay between the responses from the small and large
MB populations, with the largest CTR measured in the
large MB population. Previous in vivo studies at
40 MHz found that different-size populations of Defi-
nity (4–5 mm in diameter, 6–8 mm in diameter) had a
higher mean video intensity than Definity (1–2 mm in
diameter), indicating that large MBs contributed pre-
dominately to the fundamental response (Sirsi et al.
2010). However, it should be noted that in this study,
the Definity MBs in the small subpopulation are reso-
nant MBs (,1.7 mm in diameter) above 12 MHz. The
low CTR from the small resonant MBs suggests that at
high frequency, the large off-resonance MBs are more
suitable for enhancing the fundamental acoustic
response than small resonant MBs, although the influ-
ence of decreasing concentration of small Definity
MBs after decantation cannot be completely excluded.
An improvement of 20 dB in the CTR of SonoVue large
MBs over small MBs also supports this conclusion.
Hence decantation can be an effective method for CTR
enhancement at fundamental frequencies by increasing
the absolute number of large MBs in a limited volume,
which is particularly useful for practical in vivo pre-
clinical injection regimes where the injected volume is
often limited by animal tolerance.
In our study, we assume a concentration-matched
test, and the data in Table 4 indicate the variation in per-
centage of concentration pre- and post-decantation. This
is an estimation of the MB concentration from the Mas-
tersizer. The experiments of volume-matched or cross
section-matched boluses would also be of interest, but
such studies require knowledge of the absolute number
of microbubbles, which was beyond the measurement
scope of the equipment used in this study.
In vitro acoustic characterization of phospholipid UCAs d C. SUN et al. 549Comparison of three lipid UCAs and considerations of
their pre-clinical applications
At the same concentration, the attenuation and
CTR of the three native UCAs were found to be com-
parable when measured by transducers with frequency
,30MHz (transducers 710B, 707B and 704) as illustrated
in Figures 4 and 5. According to the results for transducer
711 (24–43 MHz), MicroMarker had a 2-dB increase in
CTR and a larger attenuation of approximate 0.5–
1 dB cm21 at 30–43 MHz in comparison to native Defi-
nity and SonoVue. This indicates a likely advantage to
the use of MicroMarker at frequencies.30 MHz. Future
work will determine whether this agent is optimally
imaged at harmonic frequencies. From the practical appli-
cation point of view, at frequencies ,30 MHz, not only
Definity, but also SonoVue could be used in a pre-
clinical setting at MB concentrations similar to those of
MicroMarker. For instance, in mice, the recommended
bolus injection of MicroMarker is 1 3 107 MBs per
50 mL (1:10 dilution, 50 mL is the total volume of diluted
bubble solution for injection) for cardiovascular, kidney
and liver imaging and 13 108 MBs per 50 mL for tumor,
retina and hindlimb imaging, respectively. A 50-mL UCA
injection of 13 107 MBs is comparable to a 1:60 dilution
for native Definity and 1:2.5 dilution for native SonoVue
UCAs. However, for 1 3 108 MBs per 50 mL, native
SonoVue faces the dilemma of low concentration within
limited injected volume (100 mL). As discussed, the ad-
vantages of using decanted large MBs for CTR enhance-
ment may aid enhancement in pre-clinical injections.
Thus, the practicalities of using SonoVue for high-
frequency in vivo application require further studies,
although the feasibility of using SonoVue has been found
to be successful for imaging in mice at 6 MHz (Browning
et al. 2011). Additionally, this study focused on the back-
scattered signals from MBs in the fundamental frequency
range; the harmonic variation as a result of decantation
would be of interest and requires further investigation.CONCLUSIONS
We characterized the acoustic attenuation and CTR
of three lipid-encapsulated UCAs using high-frequency
ultrasound from 12 to 43 MHz using a PNP of
0.56 MPa/0.58 MPa. At the same number concentration
below 30 (results for transducers 710B, 707B and 704),
the attenuation and CTR of native Definity, SonoVue
and MicroMarker are comparable, though their size dis-
tributions and encapsulated gases and shells differ signif-
icantly. At frequencies .30 MHz (results for transducer
711 [24–43 MHz]), native MicroMarker produces a
0.5 dB cm21 higher attenuation and a 2-dB higher CTR
than native Definity and SonoVue. From the CTR com-
parison of sub-populations of Definity and SonoVue,altering the size distribution and concentration through
decantation enables further enhancement for specific ap-
plications and may take full advantage of the imaging ca-
pabilities of high-frequency scanners for small animal
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